Search

Your search keyword '"Rendina, M"' showing total 575 results

Search Constraints

Start Over You searched for: Author "Rendina, M" Remove constraint Author: "Rendina, M"
575 results on '"Rendina, M"'

Search Results

1. Measurement Techniques for Low Emittance Tuning and Beam Dynamics at CESR

2. Instrumentation for the Study of Low Emittance Tuning and Beam Dynamics at CESR

3. Beam Position Monitoring System at CESR

5. Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept

6. The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients

7. Observations and predictions at CesrTA, and outlook for ILC

8. Prophylaxis of HBV-recurrence after liver transplantation in patients with HCC: Risk of HCC recurrence from a large, multicentre retrospective study from Italy

9. P394 PULMONARY HYPERTENSION IN SEARCH OF GROUP

10. Nationwide survey of liver transplantation for Primary Sclerosing Cholangitis in Italy

11. Survey on hepatic sarcoidosis in Italy

12. The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma

14. The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma

15. Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications

16. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

17. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

19. Long‐term outcomes of direct acting antivirals in post‐transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis

21. SARS-CoV-2 infection in liver transplantation is associated with favorable outcomes: an Italian transplant registry study

23. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN)

24. Development of a model based on case-mix analysis to predict 6-month patient survival after liver transplantation: a multicenter Italian study

25. Different perceptions of sustainable case-mix for liver transplantation between surgeons and hepatologists: an Italian multicenter study

26. THE CASE-MIX IN LIVER TRANSPLANTATION. DIFFERENT PERCEPTIONS (TRANSPLANT SURGEONS AND TRANSPLANT HEPATOLOGISTS) AND DIFFERENT CONCORDANCE LEVELS WITHIN CENTERS

27. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

28. Platelets and hepatocellular cancer: Bridging the bench to the clinics

29. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

35. Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation

37. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

38. THE CASE-MIX IN LIVER TRANSPLANTATION. DIFFERENT PERCEPTIONS (TRANSPLANT SURGEONS AND TRANSPLANT HEPATOLOGISTS) AND DIFFERENT CONCORDANCE LEVELS WITHIN CENTERS

39. Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis

40. Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy

41. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN)

42. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

43. The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience

44. Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

45. Quartiere IACP via Napoli a Maddaloni (CE)

47. Behind D-MELD: The Role of Primary Indication (HCV or HBV) as Significant Covariate in the Outcome Prediction after Liver Transplants.: Abstract# 1672: Poster Board #-Session: P234-IV

48. www.D-MELD.com. THE ONLINE PROGNOSTIC CALCULATOR TO OPTIMIZE DONOR-RECIPIENT MATCH: O-123

50. VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen

Catalog

Books, media, physical & digital resources